Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GingiShield is an antibacterial dental sealant developed by SelenBio Dental, Inc. for veterinary use in dogs and cats. The product incorporates SELDOX, a proprietary antibacterial technology, into a light-cured resin modality. It is designed to be applied by veterinary professionals during routine dental cleanings to create a long-lasting protective barrier on the enamel. The primary mechanism of action involves the inhibition of bacterial biofilm formation and plaque accumulation, thereby reducing the risk and progression of periodontal disease. GingiShield is the veterinary adaptation of the FDA-approved human dental sealant, DenteShield, and typically provides protection for one to two years.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GingiShield.